Brian McCarthy of Merriman Curhan Ford, an analyst who covers the stock, said in an interview that Coley shares may recover as investors realize there is still some potential for the drug.

FORBES: Magazine Article

Rollie once again joins up with Leo McCarthy (Brian Dennehy), now a private eye.

NEWYORKER: F/X 2